Radionuclide angiography for risk stratification of patients with coronary artery disease.
Radionuclide angiography has become an accepted diagnostic method that is relied upon for its rapid, accurate and quantitative capabilities to characterize LV function. This method will continue to be used extensively in the future for the evaluation of patients with CAD. In addition to its common use to measure LV function at rest, the application of radionuclide angiography to assess LV function during exercise has proven prognostic potential that can be used in the clinical decision-making process in patients with known or suspected CAD.
Bonow
R O
RO
D003327:Coronary Disease / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D005080:Exercise Test; D005500:Follow-Up Studies; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology; D009204:Myocardial Revascularization; D011379:Prognosis; D011875:Radionuclide Angiography; D012307:Risk Factors; D013318:Stroke Volume / Q000502:physiology; D015996:Survival Rate; D016277:Ventricular Function, Left / Q000502:physiology